Gold complexes with 2-selenoxo-1,3-dithiole-4,5-dithiolato

DOI: 10.1016/S0277-5387(97)00302-1

Source and publish data:

Polyhedron p. 295 - 298 (1998)

Update date:2022-08-03

Topics:

Authors:

Cerrada, Elena

Laguna, Mariano

Sorolla, Pedro A.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0277-5387(97)00302-1

The reaction of Na₂dmise (dmise = 2-selenoxo-1,3-dithiole-4,5-dithiolate) with [AuClL] in 1:2 molar ratio affords [Au₂(dmise)L₂] (L = PR₃ or CH₂PPh₃) but in 1:1 ratio in the presence of (NB

Full text of DOI:10.1016/S0277-5387(97)00302-1

Products guided by the article

Product name:Au₂(C₃S₄Se)(P(C₆H₅)3)2

Cas No:201612-30-8

R&D Labs maybe for 201612-30-8

Anhui Jiatiansen Agrochemical Co.,Ltd

Contact:15366811918

Address:chemical industrial park,xiangyu town,dongzhi county,anhui,china
Yancheng Smiling Imp & Exp Co., Ltd.

Contact:+86-515-83173586

Address:Rm1207, BLD#03, Phoenix Plaza, Juheng Road, Yancheng, Jiangsu, P.R. China
Shanghai Maxchemco Chemical Industry Co., Ltd.

Contact:(86)21-51079223

Address:No.1305-8, B241, the Ecust Park, Huajing Road, Xuhui District, Shanghai
ZHIJIANG ZENVA SINO COMMERCE AND TRADE CO., LTD.

website:http://www.zenvasino.com

Contact:+86-138-72658998

Address:Shibeishan Road,Zhijiang, Hubei, China
ABA Chemicals (Shanghai) Limited

Contact:021- 5115 9199-232

Address:Suite 18D, #201 Ningxia Road,

Relevant to this article

A calixarene with four peptide loops: An antibody mimic for recognition of protein surfaces

Doi:10.1002/anie.199726801
(1997)
Doi:10.1021/ja01137a001
(1952)
The total synthesis of lipid I

Doi:10.1021/ja016082o
(2001)
An enantioselective synthesis of cis perhydroisoquinoline LY235959

Doi:10.1021/jo9717649
(1998)
Stereocontrol in nickel mediated syntheses of cyclobutabenzenes. The selective preparation of cis and trans derivatives of 7,8-dibromocyclobutabenzene

Doi:10.1016/S0040-4020(97)10219-8
(1998)
(Phenylpiperidinyl)cyclohexylsulfonamides: Development of α_1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS)

Doi:10.1016/j.bmcl.2007.04.098
(2007)

Article Doi